PPMD's Blog – June 2014 Archive (6)

Illinois Designates Week of June 23 as Duchenne Awareness Week!

The State of Illinois is recognizing our 20th Annual Connect Conference in Chicago, IllinoisJune 26-29, 2014 by declaring the week of June 23 as Duchenne Muscular Dystrophy Awareness Week! With over 500 families and Duchenne experts expected…


Added by PPMD on June 23, 2014 at 1:30pm — No Comments

PPMD Convenes Outcome Measures Meeting

PPMD will convene a pre-conference meeting of physical therapists, occupational therapists, and clinical coordinators who specialize in the research, assessment, longitudinal data collection, and treatment of people with Duchenne, June 25 and 26 in Chicago. This meeting will precede…


Added by PPMD on June 19, 2014 at 2:30pm — No Comments

Parent Project Muscular Dystrophy Names Children's Hospital Colorado a Certified Duchenne Care Center

Children's Hospital Colorado (Children's Colorado) was named a Certified Duchenne Care Center by Parent Project Muscular Dystrophy (PPMD), the leading advocacy organization working to end Duchenne muscular dystrophy (Duchenne).

Duchenne is the most…


Added by PPMD on June 17, 2014 at 12:32pm — No Comments

"Right to Try" State Model Legislation

The Goldwater Institute of Arizona has designed state model legislation, known as a "Right to Try" bill, which would make experimental drugs available to terminally-ill patients without the FDA's approval. Under this legislation, a patient with "an advanced stage of a disease with an unfavorable prognosis and no known cure" could obtain an experimental drug that has passed…


Added by PPMD on June 16, 2014 at 12:00am — 2 Comments

Clinical Development of HT-100 for Duchenne Has Resumed

Phase 1b/2a Clinical Program Resumes Enrollment and Dosing in DMD Patients 

Preliminary Clinical Data to be presented at Upcoming Medical Conference 

Read the news release from DART Therapeutics:

DART Therapeutics Continues Clinical Development of HT-100 for Duchenne Muscular Dystrophy 

Cambridge, Mass.—June 12,…


Added by PPMD on June 12, 2014 at 12:23pm — 5 Comments

Prosensa Announces A Regulatory Path Forward for Drisapersen as a Potential Treatment for Duchenne

Prosensa Plans to Submit a New Drug Application to the FDA this Year; Dialogue with EMA continues with intent to seek approval

More good news from the FDA! This news from Prosensa continues to demonstrate that FDA recognizes the urgent needs of this community, the importance of the patient voice to understand the benefit/risk assessment, and continues to…


Added by PPMD on June 3, 2014 at 9:00am — No Comments

Monthly Archives










Need help using this community site? Visit Ning's Help Page.



© 2022   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service